
ALSO READ: Jefferies’ Cheapest Health Care Stocks to Buy
The company’s CEO said:
We performed steadily in the first quarter, with continued momentum from our Optum health services platform and year-over-year growth across our UnitedHealthcare health benefits platform offset by headwinds from new ACA taxes and Medicare Advantage funding deficiencies. We continue to help enable a more effective, more modern health care system that better serves consumers and responds to a national imperative to improve the performance of health care and reduce its costs.
The company said it repurchased $911 million in stock in the first quarter, acquiring more than 12 million shares at an average price of approximately $75 per share. Also it distributed $276 million in dividends to shareholders, representing dividend growth of 28% year-over-year.
For the full year, the company reaffirmed its forecast for revenues of $128 billion to $129 billion, with EPS in a range of $5.40 to $5.60. The consensus forecast for the full year so far calls for $5.59 per share on $128.92 billion. For the current quarter, the estimates are $1.33 per share earnings and $32.04 billion in revenue.
Note that Citigroup downgraded the stock to Neutral from Buy ahead of the earnings report.
Shares were inactive in premarket trading Thursday, after ending Wednesday at $78.19, in a 52-week range of $58.03 to $83.32. Thomson Reuters had a consensus analyst price target of around $85.09 before the results were announced.
ALSO READ: Jefferies Stocks to Buy That Could Jump From an Earnings Surprise